Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2022 · third_quarter · Q3
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Source: Senate LDA
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Reduced Costs and Continued Cures Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Reduced Costs and Continued Cures Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Reduced Costs and Continued Cures Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Reduced Costs and Continued Cures Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Seniors Prescription Drug Relief Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Seniors Prescription Drug Relief Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Seniors Prescription Drug Relief Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Seniors Prescription Drug Relief Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Reduced Costs and Continued Cures Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Reduced Costs and Continued Cures Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act.
Reduced Costs and Continued Cures Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Telehealth; H.R. 4439/S. 4010, Creating Hope Reauthorization Act; H.R. 2507 / S. 2158, Newborn Screening Saves Lives Reauthorization Act; and S. 2061, Telemental Healthcare Access Act of 2021.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Telemental Health Care Access Act of 2021
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Seniors Prescription Drug Relief Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Seniors Prescription Drug Relief Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Seniors Prescription Drug Relief Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Telehealth; H.R. 4439/S. 4010, Creating Hope Reauthorization Act; H.R. 2507 / S. 2158, Newborn Screening Saves Lives Reauthorization Act; and S. 2061, Telemental Healthcare Access Act of 2021.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Telehealth; H.R. 4439/S. 4010, Creating Hope Reauthorization Act; H.R. 2507 / S. 2158, Newborn Screening Saves Lives Reauthorization Act; and S. 2061, Telemental Healthcare Access Act of 2021.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Telehealth; H.R. 4439/S. 4010, Creating Hope Reauthorization Act; H.R. 2507 / S. 2158, Newborn Screening Saves Lives Reauthorization Act; and S. 2061, Telemental Healthcare Access Act of 2021.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Telehealth; H.R. 4439/S. 4010, Creating Hope Reauthorization Act; H.R. 2507 / S. 2158, Newborn Screening Saves Lives Reauthorization Act; and S. 2061, Telemental Healthcare Access Act of 2021.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D. Access to and reimbursement for telemedicine.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
The Newborn Screening Saves Lives Reauthorization Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D. Access to and reimbursement for telemedicine.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D.
Prescription Drug Pricing Reduction Act of 2019
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Creating Hope Reauthorization Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
H.R. 3 is the Elijah E. Cummings Lower Drug Costs Now Act Lobbying on the Medicare Part D benefit redesign section of the bill.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NEUROCRINE BIOSCIENCES, INC · Firm: NEUROCRINE BIOSCIENCES, INC
HR 3 Elijah E. Cummings Lower Drug Costs Now Act; Potential changes to structure and reimbursement for Medicare Part D.
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Support appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2022 · second_quarter · Q2
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Support appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Regulatory and legislative health care issues impacting pricing and access; Issues related to diagnosis and treatment of Tardive Dyskinesia; Issues related to diagnosis and treatment of Parkinsons Disease. Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2022 · first_quarter · 1A
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2022 · first_quarter · Q1
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2021 · fourth_quarter · 4A
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2021 · fourth_quarter · Q4
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act; H.R. 5376 Build Back Better Act.
Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
H.R. 5376 Build Back Better Act - Issues related to the Orphan Drug Tax Credit.
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2021 · third_quarter · Q3
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019; S.2327 - Seniors Prescription Drug Relief Act; H.R. 5260 Reduced Costs and Continued Cures Act.
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2021 · second_quarter · Q2
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Telehealth; H.R. 4439/S. 4010, Creating Hope Reauthorization Act; H.R. 2507 / S. 2158, Newborn Screening Saves Lives Reauthorization Act; and S. 2061, Telemental Healthcare Access Act of 2021.
Potential changes to structure and reimbursement for Medicare Part D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act of 2019.
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2021 · first_quarter · Q1
Regulatory and legislative health care issues impacting pricing and access; diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Telehealth; Creating Hope Reauthorization Act; Newborn Screening Saves Lives Reauthorization Act.
Potential changes to structure and reimbursement for Medicare Part D; Elijah E. Cummings Lower Drug Costs Now Act; Prescription Drug Pricing Reduction Act.
Support from the Department of Health and Human Services for Tardive Dyskinesia patients.
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2020 · fourth_quarter · Q4
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019.
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2020 · third_quarter · Q3
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease; Issues related to Telehealth; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act.
Potential changes to structure and reimbursement for Medicare Part D; HR 3 Elijah E. Cummings Lower Drug Costs Now Act; S. 2543 Prescription Drug Pricing Reduction Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2020 · second_quarter · 2A
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D.
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2020 · second_quarter · Q2
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D. Access to and reimbursement for telemedicine.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2020 · first_quarter · Q1
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act. S.2543 Prescription Drug Pricing Reduction Act of 2019. Structure and reimbursement for Medicare Part D.
Regulatory and legislative health care issues impacting pricing and access; Diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinsons Disease
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2019 · fourth_quarter · Q4
HR 3 Elijah E. Cummings Lower Drug Costs Now Act; Potential changes to structure and reimbursement for Medicare Part D.
Regulatory and legislative health care issues impacting pricing and access Issues related to diagnosis and treatment of Tardive Dyskinesia Issues related to diagnosis and treatment of Parkinsons Disease
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2019 · third_quarter · Q3
H.R. 3 is the Elijah E. Cummings Lower Drug Costs Now Act Lobbying on the Medicare Part D benefit redesign section of the bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEUROCRINE BIOSCIENCES, INC via NEUROCRINE BIOSCIENCES, INC
2019 · third_quarter · RR
Drug discovery and development
Drug discovery and development
Drug discovery and development
Regulatory and legislative health care issues impacting pricing and access; issues related to diagnosis and treatment of Tardive Dyskinesia; Diagnosis and treatment of Parkinson's Disease; Issues related to Telehealth; S. 2061 Telemental Healthcare Access Act of 2021; H.R. 4439/S.4010, Creating Hope Reauthorization Act; H.R. 2507/S.2158, Newborn Screening Saves Lives Reauthorization Act; H.R. 6000 Cures 2.0.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Request appropriations report language to encourage additional support from the Department of Health and Human Services for Tardive Dyskinesia patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug discovery and development
Drug discovery and development